Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP [Phase 2]
Phase 2 trial evaluating consolidation with iodine-131 labeled anti-B1 antibody after first-line CHOP therapy in patients with non-Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL) [Phase 2]
Phase 2 trial data evaluate the safety and efficacy of lenalidomide in patients with relapsed or refractory aggressive non-Hodgkin lymphoma.…
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluated administering pegfilgrastim on the same day as chemotherapy in patients with Non-Hodgkin lymphoma; the study has com…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies [Phase 1]
A phase 1 trial from St. Jude Children’s Research Hospital evaluates irinotecan with vincristine and dexamethasone in children with relapsed…
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia [Phase 3]
Phase 3 clinical trial evaluating a combination chemotherapy regimen for non-Hodgkin lymphoma or acute lymphoblastic leukemia; the study has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating chemotherapy and peripheral stem cell transplant with or without monoclonal antibody therapy in Non-Hodgkin lymph…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating combination chemotherapy for older patients with intermediate- or high-grade Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-05Clinical Trial Update: Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]
An early-phase antibody therapy was tested in patients with relapsed or refractory Non-Hodgkin lymphoma and Chronic lymphocytic leukemia; th…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) [Phase 2]
A Phase 2 clinical trial of TRM-1, a TRAIL-R1 monoclonal antibody, in relapsed or refractory Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial of a Favrille vaccine combined with GM-CSF for progressive Non-Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL [Phase 2]
A Phase 2 trial comparing entecavir and lamivudine to prevent hepatitis B reactivation in patients with non-Hodgkin lymphoma; current status…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
The trial evaluating reduced-intensity umbilical cord blood transplantation in adults with advanced hematopoietic malignancies has been term…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating Favrille vaccine therapy with sargramostim versus placebo with sargramostim after rituximab in non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Music Therapy on Nausea and Pain for Autologous Stem Cell [NA]
A completed trial evaluating music therapy to reduce nausea and pain in patients undergoing autologous stem cell transplantation for multipl…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating the combination of rituximab and interleukin-2 in patients with relapsed or refractory intermediate- or hi…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma [Phase 1]
The document reports the completion of a Phase 1 trial of AMG-479 in patients with advanced solid tumors and Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies [Phase 1]
Phase 1 pilot study evaluating haploidentical natural killer cell infusions for poor-prognosis non-AML hematologic malignancies has complete…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)
The completed trial conducted by Dana-Farber Cancer Institute evaluated SNP-based genetic markers for predicting oral mucositis risk in pati…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease [Phase 1]
Phase 1 clinical trial evaluating infusion of genetically modified T cells in post-transplant patients with relapsed disease has completed. …
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating the combination of paclitaxel and estramustine in relapsed or refractory Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
A Phase 2 study evaluating SyB L-0501 in combination with Rituximab for relapsed/refractory diffuse large B-cell lymphoma has completed, wit…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating the use of combination chemotherapy followed by peripheral stem cell transplantation in older patients with refra…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 study evaluating chemotherapy plus radiation therapy followed by peripheral stem cell transplantation for Non-Hodgkin lymphoma; the …
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas
Clinical trial update noting the completed status of a study evaluating whole-body MRI for staging Hodgkin lymphoma and Non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 dose-escalation study of TAK-901 in subjects with advanced hematologic malignancies; the trial has completed.